Clinical trial
Effects of RG1068 (Secretin) on Information Processing in Schizophrenia
NCT00235274 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00235274 |
|---|---|
| Title | Effects of RG1068 (Secretin) on Information Processing in Schizophrenia |
| Official title | Effects of RG1068 (Secretin) on Information Processing in Schizophrenia |
| Lead sponsor | Indiana University School of Medicine, Other |
| Collaborators | Shekhar, Anantha M.D., Ph.D. Repligen Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Subcutaneous Secretin |
| Enrollment | 30 |
| Start date | Nov 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Oct 10, 2005 |
| Last update posted | Mar 3, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: